Ignite Creation Date:
2024-05-06 @ 4:31 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05019586
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2021-08-14
Brief Title:
Helicobacter Pylori Resistance
Sponsor:
University Hospital of North Norway
Organization:
University Hospital of North Norway
Study Overview
Official Title:
Helicobacter Pylori Resistance A Study of Morbidity Immunological and Clinical Phenotypes
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CRIHEP
Brief Summary:
The main goal of the study was to characterize the morbidity immunological microbiolical and clinical phenotypes of patients with treated- resistance to Helicobacter pylori HP infection and the effect of triple therapy including the levofloxacin Control groups were newly diagnosed previously infected and never infected HP patients
Detailed Description:
See Nestegard O et al PLOS ONE httpsdoiorg101371journalpone0238944 September 23 2020
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None